Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Shuptrine Company was a pharmaceutical firm founded in 1877 in Savannah, Georgia, by James T. Shuptrine. The company became well-known for its proprietary patent medicines, specifically its flagship product, Tetterine, which was marketed as a highly effective ointment for skin diseases including eczema, ringworm, and tetter. Operating as both a retail pharmacy and a wholesale manufacturer, the company played a significant role in the regional healthcare market of the Southern United States for several decades. Although the original corporate entity is no longer active in its historical form, the Tetterine brand persists as a legacy dermatological product.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shuptrine Co..